Saturday, December 17, 2011

BIOCON LTD - BUY






Biocon is  one of the  largest Biopharmaceutical company in India.Till recently company was mainly concentrating in statins which is a cholesterol lowering drug .But now company is seeking various growth opportunities in other segments and paying much attention for developing  other biotechnology based branded formulations and contract research activities through its subsidiary  Syngene and Clinical research through Clyngene.Branded formulation business is expected to grow about 30% in the coming year.Recently company launched 'INSUPEN' which is a reusable insulin pen.Company's agreement with foreign pharma companies for supply of products are also a positive step.Biocon's overseas operation in the countries like Malaysia ,Germany..etc are also moving in the right direction.Oral insulin is another important step which is going through clinical trials.Biocon's last quarter performance is a tad below expectations but the sharp cut in its share price makes it an attractive buy for long term investors .CMP is Rs.261/-

20 comments :

  1. Dear VP,
    What would you suggest to choose between Biocon and Novartis? Novartis price has also come down in recent time.
    Regards
    Girish

    ReplyDelete
  2. VPJi,

    There has been closure in 2 weaving factories of Mudra? The share has fallen sharply? What is your opinion at this moment?

    Sakharam

    ReplyDelete
  3. Reason for price falling is one of the partnership drug [BYETTA] having a side effects.[Pancreatic cancer]& its falling below 301/-

    ReplyDelete
  4. Dear Girish

    Novartis is also good for long term investment and already recommended @ Rs.622 .

    See the old link below

    http://value-picks.blogspot.com/2011/02/novartis-india-ltd-buy.html

    ReplyDelete
  5. Dear Sakharam

    That is a matter of cocern

    ReplyDelete
  6. These type problems are common for any big pharma companies .I think it is a chance to buy for long term

    ReplyDelete
  7. VPji,

    Your pick APW president systems, has a delisting news, I have bought at 140 for long term perspective on your recomendation. What should be you advice on it shall I hold it or book profit?

    Regards,

    Rahul

    ReplyDelete
  8. Dear Rahul

    Since there is not much institutional investors in it,company may get the required shares for de listing .

    ReplyDelete
  9. hi vp ,orchid chem @ 115 is not a safe bet ?

    ReplyDelete
  10. Dear Valuepick,
    with today's news on FCCB, I thought Orchid Chem should have jumped upwards.but exactely reverse happened. Is it buy for long term at current levels?

    ReplyDelete
  11. Dear Sameer

    Orchid is a long term buy

    ReplyDelete
  12. DEAR VALUE PICK,

    WHAT'S YOUR OPINION ON ICSA LTD. NOW TRADING @ 24. WHAT S THE MATTER THIS KIND OF SHARP FALLING. CAN I ENTER NOW FOR LONG TERM ?

    SHAHEER THRISSUR

    ReplyDelete
  13. Dear Shaheer

    I am skeptical about ICSA and its published results for a long time.

    ReplyDelete
  14. dear sir,

    what is your view on jkagrigenetics which came down to decent levels..

    gopi

    ReplyDelete
  15. Can u plz suggest a stock for one month horizon?

    ReplyDelete
  16. sir do you track tera software, it crash 20% in tommorow's trade. what may be reason

    ReplyDelete
  17. Dear Sir,

    I am a silent admirer of your analysis and choice of the companies . however I am afraid you have got it wrong in case of Biocon . This company management - although tremendously hyped - has neither the merit not the ethics to become along term success story . Please keep away if you are looking for long term investment .
    for reasons , you can consult any Pharma industry expert.

    ReplyDelete
  18. Dear Gopi

    Uncertainty of the sanction of de-merger is bit worrying about JK Agri

    ReplyDelete
  19. Dear Praveen

    Nothing to suggest for one month

    ReplyDelete
  20. Dear aditya kumar gautam

    Not tracking Tera soft

    ReplyDelete

Followers

Tweet TopOfBlogs